MSGP — Medsmart Share Price
Last trade - 00:00- $0.00m
- $1.19m
- $0.54m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 0 | ||
| Price to Sales | 0 | ||
| EV to EBITDA | 5.97 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 23.41% | ||
Financial Summary
| Year End 31st Dec | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.02 | 0 | 0.03 | 0.05 | 0.54 | n/a | n/a | 58.72% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medsmart Group Inc. is a United States-based professional network of Medical Centers specializing in anti-aging treatments that improve the overall health and quality of life of male patients in a comfortable, casual and discreet setting. The Company owns MedSmart Wellness Centers. The Company's non-invasive treatment plans include: testosterone replacement, erectile dysfunction (ED), hypothyroidism, allergies, high cholesterol, hypertension, diabetes, physicals lab on site - immediate results, hair loss, vein treatment, cryogen therapy, weight loss and laser hair removal, hair restoration treatment, p-shot for men, PRP and stem cell treatments, Intravenous therapy.
Directors
- Zoran Cvetojevic CHM
- Adel Nasser PRE
- Manuel Canales COO
- Rajesh Babaria CTO
- Rajesh Dholakiya CTO
- Teresa Rubio TRS
- Jelena Cvetojevic DRC
- Hugo Rubio DRC
- Andrea Zecevic DRC
- Last Annual
- December 31st, 2013
- Last Interim
- September 30th, 2014
- Incorporated
- March 14th, 2019
- Public Since
- August 17th, 2005
- No. of Employees
- 4
- Sector
- Holding Companies
- Industry
- Financials
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,346,893.03
- Address
- 2980 Ne 207Th St, Suite 309, AVENTURA, 33180
- Web
- https://www.medsmartcenters.com/
- Phone
- +1 3058422244
- Auditors
- Bagell, Josephs, Levine & Company, LLC
Upcoming Events for MSGP
Similar to MSGP
1399 Internet Technology Application
Pink Sheets on Nasdaq
VG Acquisition
Pink Sheets on Nasdaq
9 Meters Biopharma
Pink Sheets on Nasdaq
Absolute Health and Fitness
Pink Sheets on Nasdaq
ACC Aviation Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 22:00 UTC, shares in Medsmart are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Medsmart last closed at $0.00 and the price had moved by +9900% over the past 365 days. In terms of relative price strength the Medsmart share price has outperformed the S&P500 Index by +9172.72% over the past year.
There is no consensus recommendation for this security.
Find out moreMedsmart does not currently pay a dividend.
Medsmart does not currently pay a dividend.
Medsmart does not currently pay a dividend.
To buy shares in Medsmart you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Medsmart had a market capitalisation of $0.00m.
Here are the trading details for Medsmart:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: MSGP
Based on an overall assessment of its quality, value and momentum Medsmart is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medsmart. Over the past six months, its share price has outperformed the S&P500 Index by +9926.53%.
As of the last closing price of $0.00, shares in Medsmart were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medsmart PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Medsmart's management team is headed by:
- Zoran Cvetojevic - CHM
- Adel Nasser - PRE
- Manuel Canales - COO
- Rajesh Babaria - CTO
- Rajesh Dholakiya - CTO
- Teresa Rubio - TRS
- Jelena Cvetojevic - DRC
- Hugo Rubio - DRC
- Andrea Zecevic - DRC